Related Experiment Video

Updated: Aug 17, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients

Philipp S Goerttler1, Cordula Steimle, Edith März

  • 1Department of Experimental Anaesthesiology, University Hospital Freiburg, Breisacher Str. 66, 79106 Freiburg, Germany.

Blood
|June 30, 2005
PubMed

Insights

The Janus kinase 2 (Jak2) V617F mutation strongly correlates with specific molecular markers in myeloproliferative disorders (MPDs). This finding is consistent across polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF).

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • The Janus kinase 2 (Jak2) V617F mutation is prevalent in myeloproliferative disorders (MPDs).
  • Previous molecular markers like endogenous erythroid colonies (EECs), polycythemia rubra vera 1 (PRV-1) overexpression, and decreased c-Mpl expression have been noted in MPDs.
  • The co-occurrence of Jak2V617F with these markers in essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF) requires investigation.

Purpose of the Study:

  • To investigate the correlation between the Jak2V617F mutation and established molecular markers in MPDs.
  • To determine if the Jak2V617F mutation is present in ET and IMF patients with specific molecular profiles.
  • To analyze the relationship between Jak2V617F, EECs, PRV-1, and c-Mpl levels across different MPD subtypes.

Main Methods:

  • Analysis of Janus kinase 2 (Jak2) DNA sequence in 78 myeloproliferative disorder (MPD) patients.
  • Assessment of endogenous erythroid colony (EEC) growth.
  • Measurement of polycythemia rubra vera 1 (PRV-1) expression and c-Mpl levels.

Main Results:

  • The Jak2V617F mutation showed a very high correlation with PRV-1 overexpression (P < .001).
  • A strong correlation was observed between the Jak2V617F mutation and the ability to form EECs (P < .001).
  • These correlations were consistent across all three MPD subtypes studied: polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF).

Conclusions:

  • The Jak2V617F mutation is significantly associated with PRV-1 overexpression and endogenous erythroid colony formation in MPDs.
  • These findings reinforce the role of the Jak2V617F mutation as a key molecular driver across PV, ET, and IMF.
  • The study supports the utility of these molecular markers in understanding the pathogenesis of myeloproliferative neoplasms.

More Related Videos

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...